We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Spectral Md Holdings Ltd | LSE:SMD | London | Ordinary Share | CMN STK USD0.001 (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 58.00 | 60.00 | 65.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMSMD
RNS Number : 2557B
Spectral MD Holdings, Ltd.
01 June 2023
Spectral MD Holdings, Ltd
("Spectral MD" or the "Company")
Block Listing Six Monthly Return
LONDON, U.K. AND DALLAS, TX, U.S -Spectral MD Holdings, Ltd. (AIM: SMD), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, provides the following information in connection with its block admissions pursuant to AIM Rule 29 and Schedule Six of the AIM Rules for Companies:
Name of applicant: Spectral MD Holdings, Ltd. Name of scheme: 2018 Long-Term Incentive Plan ---------------------------------- Period of return: From: 8 November To: 7 May 2023 2022 ---------- ------------- ----- ------------ Balance of unallotted securities 2,000,000 Ordinary shares under scheme(s) from previous return: ---------------------------------- Plus: The amount by which the - block scheme(s) has been increased since the date of the last return (if any increase has been applied for): ---------------------------------- Less: Number of securities issued/allotted 104,451 Ordinary shares under scheme(s) during period: ---------------------------------- Equals: Balance under scheme(s) 1,895,549 Ordinary shares not yet issued/allotted at end of period: ---------------------------------- Name of contact: Vince Capone, General Counsel/Corporate Secretary Telephone number of contact: +1 972 499-4934 ----------------------------------------
For further information please contact:
Spectral MD Holdings, Ltd. Wensheng Fan, Chief Executive Officer IR@Spectralmd.com Nils Windler, Chief Financial Officer via Walbrook PR SP Angel Corporate Finance LLP (NOMAD and Joint Broker for Spectral MD) Stuart Gledhill / Harry Davies-Ball (Corporate Finance) Tel: +44 (0)20 3470 0470 Vadim Alexandre / Rob Rees (Sales & Broking) The Equity Group Inc. (US Investor Relations) Devin Sullivan dsullivan@equityny.com Tel: 212-836-9608 Walbrook PR Ltd (UK Media & Investor Relations) Paul McManus / Louis Ashe-Jepson /Alice Woodings spectralMD@walbrookpr.com Tel: +44 (0)20 7933 8780
About Spectral MD
Spectral MD is a predictive AI company focused on medical diagnostics for faster and more accurate treatment decisions in wound care for burn, DFU, and future clinical applications. At Spectral MD, we are a dedicated team of forward-thinkers striving to revolutionize the management of wound care by "Seeing the Unknown"(R) with our DeepView(R) Wound Diagnostics System. The Company's DeepView(R) platform is the only predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. With algorithm-driven results that substantially exceed the current standard of care, Spectral MD's diagnostic platform is expected to provide faster and more accurate treatment insight, significantly improving patient care and clinical outcomes. For more information, visit the Company at: www.spectralmd.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
BLRNKDBBCBKDPPN
(END) Dow Jones Newswires
June 01, 2023 02:00 ET (06:00 GMT)
1 Year Spectral Md Chart |
1 Month Spectral Md Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions